NCT01587118 An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder Status COMPLETED Phase PHASE4
NCT01585584 Triple-Therapy in Patients With HCV Genotype 3 Who Previously Failed Treatment Status COMPLETED Phase PHASE3
NCT01583647 A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158) Status TERMINATED Phase PHASE1
NCT01582308 A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142) Status COMPLETED Phase PHASE1
NCT01581710 Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children. Status COMPLETED Phase NA
NCT01580228 A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714) Status COMPLETED Phase PHASE3
NCT01569152 Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008) Status TERMINATED Phase PHASE2
NCT01568515 Electronic Messaging to Increase Human Papillomavirus Vaccine Utilization and Adherence Among College Students Status COMPLETED Phase EARLY_PHASE1
NCT01567813 Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070) Status COMPLETED Phase N/A
NCT01564459 Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021) Status COMPLETED Phase PHASE2
NCT01558674 A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011) Status TERMINATED Phase PHASE1
NCT01557504 A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296) Status COMPLETED Phase PHASE1
NCT01556451 ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034) Status COMPLETED Phase PHASE4
NCT01554852 Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients Status UNKNOWN Phase PHASE3
NCT01554189 A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002) Status TERMINATED Phase PHASE1
NCT01554176 Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022) Status TERMINATED Phase PHASE2
NCT01552122 Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050) Status WITHDRAWN Phase PHASE3
NCT01550224 Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE2